Product NDC: | 14537-966 |
Proprietary Name: | AS |
Non Proprietary Name: | Dextrose Monohydrate, Sodium Citrate, Sodium Chloride, Sodium Phosphate, Monobasic, Monohydrate, Citric Acid Monohydrate and Adenine |
Active Ingredient(s): | .03; .042; 1.1; .41; .588; .276 g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL & nbsp; Dextrose Monohydrate, Sodium Citrate, Sodium Chloride, Sodium Phosphate, Monobasic, Monohydrate, Citric Acid Monohydrate and Adenine |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 14537-966 |
Labeler Name: | CaridianBCT, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA001214 |
Marketing Category: | NDA |
Start Marketing Date: | 20020529 |
Package NDC: | 14537-966-10 |
Package Description: | 100 mL in 1 BAG (14537-966-10) |
NDC Code | 14537-966-10 |
Proprietary Name | AS |
Package Description | 100 mL in 1 BAG (14537-966-10) |
Product NDC | 14537-966 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dextrose Monohydrate, Sodium Citrate, Sodium Chloride, Sodium Phosphate, Monobasic, Monohydrate, Citric Acid Monohydrate and Adenine |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20020529 |
Marketing Category Name | NDA |
Labeler Name | CaridianBCT, Inc. |
Substance Name | ADENINE; CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; SODIUM CITRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
Strength Number | .03; .042; 1.1; .41; .588; .276 |
Strength Unit | g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL |
Pharmaceutical Classes |